Changes in anthropometric and blood 25-hydroxyvitamin D measurements in antenatal vitamin supplemented gestational diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials
Open Access
- 1 September 2021
- journal article
- review article
- Published by Galenos Yayinevi in Journal of the Turkish-German Gynecological Association
- Vol. 22 (3), 217-234
- https://doi.org/10.4274/jtgga.galenos.2021.2020.0197
Abstract
Objective: Gestation weight (GW), body mass index (BMI), and blood 25-hydroxyvitamin D [25(OH)D] level during pregnancy are important determinants of the gestational outcomes. This study aimed to study how these parameters vary between antenatal vitamin D recipients and non-recipients in gestational diabetes mellitus (GDM) patients. Material and Methods: The randomized controlled trials comparing these outcomes between vitamin D recipient and non-recipient GDM patients were searched in electronic databases (PubMed, Embase, and Scopus). The reviewed studies' data were abstracted and critically appraised using the Cochrane tool. The estimation of the weighted mean difference for GW and BMI and standardized mean difference (SMD) for 25(OH)D levels occurred by juxtaposing the interventions meta-analytically (random-effect model). The statistical inconsistency was determined by Chi(2) and I-2 method. The statistical significance was estimated at p<0.05 and 95% confidence interval (CI). Results: Eleven eligible trials (all Iran-based, except one), sourcing data from about 875 GDM patients, were reviewed. Overall, the risk of bias was low, except for selection and performance bias. On random-effect model meta-analysis, the 25(OH)D levels of the GDM patients favored the vitamin D recipients when compared to non-vitamin D ( SMD 1.97, 95% CI: 1.06- 2.88, p<0.001; I-2 96.2%, p of Chi(2) <0.001) and placebo (SMD 1.86, 95% CI: 0.95-2.77, p<0.001; I-2 95.3%, p of Chi(2) <0.001) recipients, respectively. On meta-regression, sample size was a predictor of the observed heterogeneity. For GW and BMI the interventions did not differ statistically significantly. Conclusion: In GDM patients, antenatal use of vitamin D aids in the rise of blood 25(OH)D levels. However, vitamin D supplementation did not affect change in GW or BMI.Keywords
This publication has 51 references indexed in Scilit:
- Randomized placebo-controlled trial of high-dose prenatal third-trimester vitamin D3 supplementation in Bangladesh: the AViDD trialNutrition Journal, 2013
- Maternal weight gain in women with gestational diabetes mellitusjpme, 2013
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2012
- Low gestational weight gain improves infant and maternal pregnancy outcomes in overweight and obese Korean women with gestational diabetes mellitusGynecological Endocrinology, 2010
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationJournal of Clinical Epidemiology, 2009
- Vitamin D deficiency and supplementation during pregnancyClinical Endocrinology, 2009
- Increasing Prevalence of Gestational Diabetes MellitusDiabetes Care, 2007
- Grading quality of evidence and strength of recommendationsBMJ, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003